| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 01/25/2007 | WO2007010989A1 Neuronal differentiation-inducing peptide and use thereof |
| 01/25/2007 | WO2007010941A1 Antigen and monoclonal antibody capable of recognizing the antigen |
| 01/25/2007 | WO2007010651A1 Novel proteins and method of using the same |
| 01/25/2007 | WO2007010623A1 Novel polypeptide and method for producing the same |
| 01/25/2007 | WO2007010291A1 Vaccine |
| 01/25/2007 | WO2007010287A1 Biological materials and uses thereof |
| 01/25/2007 | WO2007010133A2 Polypeptides having an activity in the mtbe degradation path and uses thereof |
| 01/25/2007 | WO2007009978A1 Polypeptides having antimicrobial activity and polynucleotides encoding same |
| 01/25/2007 | WO2007009950A1 Method for the purification of g-csf |
| 01/25/2007 | WO2007009816A2 Plexin d1 as a target for tumor diagnosis and therapy |
| 01/25/2007 | WO2007009403A1 Growth-stimulating polypeptides for use in fish and crustaceans |
| 01/25/2007 | WO2007009359A1 Thymosin beta 4 derivatives and use thereof |
| 01/25/2007 | WO2007009351A1 A method of secretion expression of lysostaphin in escherichia coli at high level |
| 01/25/2007 | WO2007009208A1 Poly(ethylene glocol) modified human gm-csf with increased biological activity |
| 01/25/2007 | WO2007009194A1 Sra binding protein |
| 01/25/2007 | WO2006130503A3 Errϝ peptide fragment complexes and uses thereof in drug discovery |
| 01/25/2007 | WO2006122986A3 Use of penicillin-binding proteins or polynucleotides or antibodies thereof for preventing or treating bacterial infections |
| 01/25/2007 | WO2006105219A3 T cell therapy for the treatment of cachexia and chronic diseases |
| 01/25/2007 | WO2006097708A3 Affinity purification of protein |
| 01/25/2007 | WO2006097537A3 Acylated glp-1 compounds |
| 01/25/2007 | WO2006083927A3 Antimicrobial agent |
| 01/25/2007 | WO2006078798A3 RNA INTERFERENCE MEDIATED INHIBITION OF RETINOBLASTOMA (RB1) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) |
| 01/25/2007 | WO2006076014A3 Interferon-alpha constructs for use in the treatment of sars |
| 01/25/2007 | WO2006071200A3 Chinese hamster apoptosis-related genes |
| 01/25/2007 | WO2006067602A3 Process for cell surface expression of human alpha id adrenergic receptor |
| 01/25/2007 | WO2006067063A3 Screening methods for identification of modulators of cytokine class i |
| 01/25/2007 | WO2006053125A3 Gp201: methods and compositions for treating cancer |
| 01/25/2007 | WO2006050945A3 Tubulin mutation diagnostic |
| 01/25/2007 | WO2006047505A3 Crystal structure of the c-fms kinase domain |
| 01/25/2007 | WO2006046072A3 VWFA AND/OR ANT_IG DOMAIN CONTAINING PROTEINS |
| 01/25/2007 | WO2006031607A3 A method of treating cancer |
| 01/25/2007 | WO2006015165A3 Optimized interferon-beta gene |
| 01/25/2007 | WO2005113837A3 Truncated hepatitis c virus ns5 domain and fusion proteins comprising same |
| 01/25/2007 | WO2005113773A9 Polynucleotides for the detection of escherichia coli 0157:h7 and escherichia coli 0157:nm verotoxin producers |
| 01/25/2007 | WO2005097998A3 Il-18 specific polypeptides and therapeutic uses thereof |
| 01/25/2007 | WO2005019420A3 Chimeric receptors with disrupted dileucine motifs |
| 01/25/2007 | WO2004052186A3 Expressed genes that define the osteoclast phenotype |
| 01/25/2007 | US20070022502 Plant seed specific promoters |
| 01/25/2007 | US20070022501 selecting plants with decreased size or mass; selecting the plants for an early-flowering phenotype; controlling fertility; plant growth regulators; forming transgenic plants |
| 01/25/2007 | US20070022499 Alteration of oil traits in plants |
| 01/25/2007 | US20070022493 Fertile transgenic corn plants |
| 01/25/2007 | US20070022489 Modulation of coffee flavour precursor levels in green coffee grains |
| 01/25/2007 | US20070022483 Animal model involving transgenic manipulation of amyloid precursor protein; useful for testing potential therapeutic agents for the treatment of neurodegenerative disorders, in particular Alzheimer's disease; drug screening |
| 01/25/2007 | US20070021925 Method and apparatus for searching for protein amphiphilic secondary structure region |
| 01/25/2007 | US20070021917 3-structure of a whole integrin $g(a) v$g(b) extracellular region and uses therefor |
| 01/25/2007 | US20070021601 Nucleic acid amino acid sequences relating to Streptococcus pneumoniae for diagnostics and therapeutics |
| 01/25/2007 | US20070021600 Nucleic acid and amino acid sequences relating to Enterococcus faecalis for diagnostics and therapeutics |
| 01/25/2007 | US20070021599 Comprises transport proteins diagnosis and treatment of cell proliferative disorders; antiproliferative agents; gene expression inhibition; detecting differential methylation patterns in the SLC5A8 gene which encode novel sodium solute symporter members |
| 01/25/2007 | US20070021598 Mutants of green fluorescent protein |
| 01/25/2007 | US20070021597 Expressed sequence tags (EST); nucleotide sequence encoding signal peptide; vectors |
| 01/25/2007 | US20070021596 Useful as a candidate for a vaccine against ticks, particularly Ornithodoros moubata, tick-borne infections such as rickettsiosis, filariasis, Q fever, African recurrent fever, or viral encephalitis |
| 01/25/2007 | US20070021594 Ligand-binding reagents for quenching and improved purification of lipidated proteins |
| 01/25/2007 | US20070021593 for use in the treatment of inflammation and ischemia-reperfusion injury |
| 01/25/2007 | US20070021592 NPC1L1 (NPC3) and methods of use thereof |
| 01/25/2007 | US20070021591 Compositions and methods for protein deaggregation |
| 01/25/2007 | US20070021590 Secreted protein family |
| 01/25/2007 | US20070021589 Obesity-related genes |
| 01/25/2007 | US20070021588 Alpha macroglobulin protein family members |
| 01/25/2007 | US20070021374 polypeptides derived from Streptococcus pneumoniae including surface or secreted proteins or parts thereof, that are useful as molecular targets for diagnostics, prophylaxis and treatment of bacterial infection; vaccines |
| 01/25/2007 | US20070021373 Administering polypeptide which elicits an immune response |
| 01/25/2007 | US20070021372 Nucleic acid and amino acid sequences relating to Streptococcus pneumoniae for diagnostics and therapeutics |
| 01/25/2007 | US20070021371 Nucleic acid and amino acid sequences relating to Streptococcus pneumoniae for diagnostics and therapeutics |
| 01/25/2007 | US20070021370 Administering polypeptide which elicits immune response; antibodies useful as probes for detection; vaccines |
| 01/25/2007 | US20070021369 Nucleic acid and amino acid sequences relating to streptococcus pneumoniae for diagnostics and therapeutics |
| 01/25/2007 | US20070021368 Administering polypeptide to elicit immune response; pneumonia, otitis media; biodrugs |
| 01/25/2007 | US20070021350 Conjugates useful in the treatment of prostate cancer |
| 01/25/2007 | US20070021341 Treatment of autoimmune conditions with Copolymer 1 and related Copolymers |
| 01/25/2007 | US20070021332 Helminth-derived antigens having capacity of providing protection against parasites |
| 01/25/2007 | US20070021327 Methods and compositions for treatment of tumors using nucleic acid ligands to platelet-derived growth factor |
| 01/25/2007 | US20070021324 Process for preparation of mixtures of polypeptides using purified hydrobromic acid |
| 01/25/2007 | US20070021321 determining whether catechin or an antibody has the same pharmacological effect as that of epigallocatechin gallate, on inhibiting cell proliferation, angiogenesis or cancer cell metastasis, as a neuroprotectant, a viricide, an antiallergen and as a antiarteriosclerotic agent |
| 01/25/2007 | US20070020746 Staphylococcus aureus polynucleotides and sequences |
| 01/25/2007 | US20070020739 Enzyme gene participating in the synthesis of polyester and process for producing polyester using the same |
| 01/25/2007 | US20070020735 IL-17 homologous polypeptides and therapeutic uses thereof |
| 01/25/2007 | US20070020734 Interferon-alpha polypeptides and conjugates |
| 01/25/2007 | US20070020733 Polypeptide for use in the diagnosis and detection of bacterial infections |
| 01/25/2007 | US20070020732 Inflammatory response protein for use in developing vaccines against allergic diseases; allergic response modulation; antiallergens; signal transducer specifically expressed in human mast cells |
| 01/25/2007 | US20070020730 Method for overexpression of zwitterionic polysaccharides |
| 01/25/2007 | US20070020729 Novel collectin |
| 01/25/2007 | US20070020728 Muteins of apolipoprotein D |
| 01/25/2007 | US20070020724 94 human secreted proteins |
| 01/25/2007 | US20070020714 Biosensor with increased signal intensity to sugar concentration that is a maltose binding protein bound to enhanced cyan, enhanced blue, or enhanced green fluorescent protein on one end and enhanced yellow, enhanced green, or red fluorescent protein on the other through dipeptide linkages |
| 01/25/2007 | US20070020709 IGF binding proteins |
| 01/25/2007 | US20070020708 Nucleotide sequences coding regulatory proteins comprising death domains for identifying modulators of nuclear factor kappa beta activity and treatments for cell proliferative and neurodegenerative diseases; gene expression inhibition |
| 01/25/2007 | US20070020706 Truncated proteins as cancer markers |
| 01/25/2007 | US20070020698 IGF binding proteins |
| 01/25/2007 | US20070020696 Appl proteins as rab5 effectors |
| 01/25/2007 | US20070020695 Immunogenic peptide sequences; antibodies directed against particular amino acid regions of Hsp70B' |
| 01/25/2007 | US20070020692 Methods of assaying connective tissue growth factor |
| 01/25/2007 | US20070020690 Method for site-specific protein modifications |
| 01/25/2007 | US20070020686 Db, the receptor for leptin, nucleic acids encoding the receptor, and uses thereof |
| 01/25/2007 | US20070020684 Structure of a glucocorticoid receptor ligand binding domain comprising an expanded binding pocket and methods employing same |
| 01/25/2007 | US20070020681 Analyte reacts to form a binding pair, localized on a solid phase support, using an analyte-dependent enzyme activation system; an enzyme reacts with the labeled conjugate forming an activated conjugate, binds to a receptor site for the conjugate; labeled, glycoside ester substituted benzene substrate |
| 01/25/2007 | US20070020674 Novel gene defective in APECED and its use |
| 01/25/2007 | US20070020632 Method for selective inhibition of human n-myc gene in n-myc expressing tumors through antisense and antigen peptido-nucleic acids (pna) |
| 01/25/2007 | US20070020627 Artificial transcription factors |
| 01/25/2007 | US20070020625 Sequence of the photorhabdus luminescens strain tt01 genome and uses |
| 01/25/2007 | US20070020624 Nucleic acid and amino acid sequences relating to Pseudomonas aeruginosa for diagnostics and therapeutics |
| 01/25/2007 | US20070020614 Development of novel anti-microbial agents based on bacteriophage genomics |
| 01/25/2007 | US20070020344 inhibition and/or prevention of on-growth of biological organisms on objects or living beings, includes at least one cyclotide, and a suitable carrier medium |